Year All202420232022202120202019 Nov 29, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Nov 05, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results Nov 01, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Oct 02, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Sep 03, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Aug 08, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results Aug 02, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Jul 01, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Jun 28, 2024 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors May 31, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 05, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
Aug 08, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
Jun 28, 2024 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
